Showing results (1611-1620 of 3,615) with videos related to
Sort By:
Pageof 362
Journal of Viral Hepatitis|November 3, 2020
Hepatitis C virus infection mortality trends according to three definitions with special concern for the baby boomer birth cohortMing-Jen Sheu, Fu-Wen Liang, Tsung-Hsueh LuJournal of Viral Hepatitis|June 9, 2021
Direct antiviral agent treatment leads to rapid and significant fibrosis regression after HCV eradicationQian Kang, Jinghang Xu, Hao Luo, et al.Journal of Viral Hepatitis|May 2, 2022
Hepatitis C virus eradication ameliorates the prognosis of advanced hepatocellular carcinoma treated with sorafenibAkifumi Kuwano, Masayoshi Yada, Shigehiro Nagasawa, et al.Journal of Viral Hepatitis|July 24, 2022
Role of hepatitis B surface antibody in seroreversion of hepatitis B surface antigen in patients achieving hepatitis B surface antigen loss with pegylated interferon-based therapyNa Gao, Huiying Yu, Jing Zhang, et al.Journal of Viral Hepatitis|February 3, 2016
Natural killer cells in highly exposed hepatitis C-seronegative injecting drug usersM M Mina, B Cameron, F Luciani, et al.Journal of Viral Hepatitis|February 4, 2016
Public health clinic-based hepatitis C testing and linkage to care in BaltimoreO Falade-Nwulia, S H Mehta, J Lasola, et al.Journal of Viral Hepatitis|January 16, 2016
Cerebral microglia activation in hepatitis C virus infection correlates to cognitive dysfunctionH Pflugrad, G-J Meyer, M Dirks, et al.Journal of Viral Hepatitis|December 10, 2014
Simeprevir added to peginterferon and ribavirin lessens time with fatigue, depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST-1, QUEST-2 and PROMISE studiesJ Scott, L Gilles, M Fu, et al.Journal of Viral Hepatitis|September 22, 2015
Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patientsJ V Fernández-Montero, P Barreiro, C de Mendoza, et al.Journal of Viral Hepatitis|September 25, 2015
Genetic variation in PTX3 and plasma levels associated with hepatocellular carcinoma in patients with HCVR F Carmo, D Aroucha, L R S Vasconcelos, et al.Pageof 362